LIN Today - Aug 10: Price Target Cut

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

LIN Today - Aug 10: Price Target Cut

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly neighborhood investor, and today I’m breaking down what went down with Linde, or LIN, for August 10. Spoiler alert: it was a bit of a red day. The stock dipped just a smidge, down about a third of a percent.

So, what happened? Well, Linde started the day looking pretty steady but ended up getting a little pressure from some analysts. BMO Capital Markets decided to cut their price target for Linde, which kinda put a damper on things. You know how it is—when analysts start lowering their targets, it makes people a bit jittery.

Now, let’s talk about the why. BMO's reasoning was tied to some challenges they see in Linde's healthcare unit. They’re saying that the company’s facing some headwinds there, which is never a good sign. It’s like when you’re trying to enjoy a nice day out, and suddenly it starts raining. Nobody wants that! So, this news got folks a bit worried, and that’s why you saw some selling happening.

On the flip side, Goldman Sachs still has a buy rating on Linde, but they also made a small adjustment to their price target, dropping it from $585 to $580. It’s like a mixed bag of news—some good, some not so great.

One thing to keep in mind is that Linde’s been on a bit of a rollercoaster lately, so it’s worth keeping an eye on how this healthcare unit situation plays out. They’ve got some big expectations to meet, and investors are gonna be watching closely.

So, to wrap it up, Linde had a rough day mainly due to those analyst cuts, but there’s still some support out there from other firms. Just remember, this is all for info and entertainment, not financial advice. Catch you later!

まだレビューはありません